Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program Clinical research trials and Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program. Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program clinical trial. Test subjects typically receive the most effective healthcare possible for their Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "F" Clinical Trials Conditions > Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program

Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program



Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program

For Condition: Prostate Cancer
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , Urological Research Foundation
Synopsis: There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination
Details:
Eligibility:
Study Type:
  Observational, Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Minimum Age/Maximum Age: 40 Years/
Genders: Male
Protocol Entry Criteria: Men with prostate cancer diagnosed through the PSA screening study
Total Enrollment: 

Location and Contact Information:

Washington University School of Medicine
St. Louis,  Missouri,  63110
United States
 


Additional Information:
Study ID Numbers:
  NCRR-M01RR00036-0838; 
Study Start Date: 
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035217

Other Prostate Cancer Studies:
1. The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

2. Lycopene In Preventing of Prostate Cancer

3. Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) with Escalating Doses of Docetaxel in Patients with Metastatic Androgen-Independent Prostate Cancer

4. Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

5. A Phase III, Randomized Study of Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer

Related Studies:

Other Prostate Cancer Clinical Trials
Other Missouri Clinical Trials
Other St. Louis Clinical Trials

Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program

Modify your Search

  Other Prostate Cancer Clinical Trials
  Other Missouri Clinical Trials
  Other St. Louis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103